SAB Biotherapeutics Inc (SABS): 1.11 High PM

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

SAB Biotherapeutics Inc (SABS)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	3340
Posts	84306
Boards Moderated	7
Alias Born	10/05/2005

Re: None

Thursday, 04/13/2023 8:13:34 AM

Thursday, April 13, 2023 8:13:34 AM

1.11 High PM

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent SABS News

SAB Biotherapeutics Provides SAB-142 Trial Update • GlobeNewswire Inc. • 04/16/2024 11:15:00 AM
SAB Biotherapeutics to Present at INNODIA Annual Meeting • GlobeNewswire Inc. • 04/08/2024 11:15:00 AM
SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/04/2024 11:15:00 AM
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results • GlobeNewswire Inc. • 03/29/2024 11:15:00 AM
SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment • GlobeNewswire Inc. • 03/25/2024 02:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:30:11 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:55:10 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:45:19 PM
SAB Biotherapeutics to Present at the BIO CEO & Investor Conference • GlobeNewswire Inc. • 02/23/2024 01:00:00 PM
SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/08/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 12:53:44 PM
SAB Biotherapeutics Announces Executive Leadership Change • GlobeNewswire Inc. • 02/02/2024 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 09:15:19 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/26/2024 09:00:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 10:00:09 PM
SAB Biotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 01/23/2024 10:58:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:21:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 02:00:08 PM
SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split • GlobeNewswire Inc. • 01/02/2024 09:30:00 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/18/2023 02:34:03 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/08/2023 10:26:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 10:00:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 12:40:46 PM
SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 Diabetes • GlobeNewswire Inc. • 11/29/2023 12:30:00 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/29/2023 05:15:09 AM

More SABS News

InvestorsHub NewsWire

Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM

North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM

Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM

Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM

BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM

Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow